
    
      The purpose of this study is to evaluate safety and efficacy of rituximab, with and without
      methotrexate, in joints, enthesium and skin in psoriatic arthritis patients with inadequate
      response to methotrexate who have either not tried anti-TNF therapy or have had inadequate or
      failed response to anti-TNF therapy. To explore biologic mechanism of action via histological
      and immunohistochemical evaluation of pre and post treatment biopsies of psoriatic plaques.
    
  